Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Early Parkinson's Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT01538329
What this trial is testing

Amantadine and L-DOPA-induced Dyskinesia in Early Parkinson's Disease

Who this might be right for
Parkinson Disease
University Hospital, Toulouse 210
Not applicableLooking for participantsNCT06248073
What this trial is testing

Effectiveness of Online Program and Task-related Training for Parkinson's Disease

Who this might be right for
Parkinson DiseaseOccupational TherapyTelerehabilitation+1 more
Chang Gung University 100
Testing effectiveness (Phase 2)Study completedNCT05348785
What this trial is testing

Learn About the Safety of BIIB122 Tablets and Whether They Can Slow the Worsening of Early-Stage Parkinson's Disease in Adults Between the Ages of 30 and 80

Who this might be right for
Parkinson Disease
Biogen 650
Large-scale testing (Phase 3)Ended earlyNCT01028586
What this trial is testing

MOTION, Safinamide in Early Idiopathic Parkinson's Disease (IPD), as add-on to Dopamine Agonist (Extension of Trial 27918)

Who this might be right for
Idiopathic Parkinson's Disease
Newron Pharmaceuticals SPA 507
Testing effectiveness (Phase 2)Study completedNCT00148486
What this trial is testing

A Fourteen-Week Placebo-Controlled Dose-Response Efficacy and Safety Study of NS 2330 in Early Parkinson's Disease Patients (Study for Proof of Concept in Early Parkinson's Disease of a Triple Reuptake Inhibitor, NS 2330 / SCEPTRE)

Who this might be right for
Parkinson Disease
Boehringer Ingelheim 261
Large-scale testing (Phase 3)Study completedNCT00203060
What this trial is testing

Effectiveness, Tolerability and Safety of Rasagiline in Early Parkinson's Disease Patients Not Treated With Levodopa

Who this might be right for
Parkinson's Disease
Teva Neuroscience, Inc. 404
Large-scale testing (Phase 3)Study completedNCT00036218
What this trial is testing

Study Evaluating Sumanirole for the Treatment of the Signs and Symptoms of Early Parkinson's Disease.

Who this might be right for
Parkinson Disease
Pfizer 600
Testing effectiveness (Phase 2)UnknownNCT04220762
What this trial is testing

Determine the Dose of WIN-1001X by Evaluating Efficacy and Safety in Early Parkinson's Disease Patients

Who this might be right for
Parkinson Disease
Medi Help Line 188
Not applicableLooking for participantsNCT06232772
What this trial is testing

Research on Novel Biomarkers for Early Diagnosis of Parkinson's Disease:An Observational, Multicenter, Non-Randomized Controlled Study

Who this might be right for
Parkinson's Disease
Yousheng Xiao 600
Not applicableLooking for participantsNCT02760108
What this trial is testing

Parkinson's Families Project

Who this might be right for
Parkinson's DiseaseParkinsonism
University College, London 2,000
Not applicableStudy completedNCT05699460
What this trial is testing

Pre-Gene Therapy Study in Parkinson's Disease and Multiple System Atrophy

Who this might be right for
Parkinson's DiseaseMultiple System Atrophy, Parkinson VariantMultiple System Atrophy
AskBio Inc 73
Large-scale testing (Phase 3)Study completedNCT00332917
What this trial is testing

An Open Label SLV308 Safety Extension to Study S308.3.001 in Early PD Patients

Who this might be right for
Early Stage Parkinson's Disease
Solvay Pharmaceuticals 224
Not applicableStudy completedNCT00291265
What this trial is testing

Measures of Motor Impairment in Early Parkinson's Disease

Who this might be right for
Parkinson's Disease
National Institute of Neurological Disorders and Stroke (NINDS) 10
Post-approval studies (Phase 4)Study completedNCT00402233
What this trial is testing

A Randomized, Double-blind, Active (Pramipexole 0.5 mg Tid) and Placebo Controlled, Study of Pramipexole Given 0.5 mg and 0.75 mg Bid Over 12-week Treatment in Early Parkinson's Disease (PD) Patients

Who this might be right for
Parkinson Disease
Boehringer Ingelheim 312
Not applicableStudy completedNCT03983785
What this trial is testing

The Effect of Pilates and Elastic Taping on Balance and Postural Control in Early Parkinson's Disease

Who this might be right for
Parkinson Disease
Dokuz Eylul University 31
Early research (Phase 1)Study completedNCT04045678
What this trial is testing

A Multiple Ascending Dose Study With LY03003 in Patients With Early-stage Parkinson's Disease

Who this might be right for
Parkinson Disease
Luye Pharma Group Ltd. 30
Not applicableUnknownNCT03047408
What this trial is testing

Evolution of RBD in PD

Who this might be right for
REM Sleep Behavior DisorderParkinson's Disease
University Hospital, Clermont-Ferrand 50
Testing effectiveness (Phase 2)Active Not RecruitingNCT04386317
What this trial is testing

Terazosin Effect on Cardiac Changes in Early Parkinson's Disease

Who this might be right for
REM Sleep Behavior DisorderPre-motor Parkinson's DiseaseSymptomatic Parkinson Disease
Cedars-Sinai Medical Center 15
Testing effectiveness (Phase 2)Study completedNCT00833690
What this trial is testing

Safety of Urate Elevation in Parkinson's Disease

Who this might be right for
Parkinson Disease
The Parkinson Study Group 75
Early research (Phase 1)UnknownNCT04922190
What this trial is testing

Promoting Physical Activity Engagement for People With Early-mid Stage Parkinson's Disease (Engage-PD)

Who this might be right for
Parkinson Disease
Teachers College, Columbia University 100
Next Page